Device Trial Radar · NCT01610622
Estimation of Cardiac Output in Neonatal ICU Using an Ultrasound Dilution Technique
Last checked: Nov 20, 2026Latest source record: May 27, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
7
Actual
Start
Mar 2012
Primary completion
May 2013
Study completion May 2013
Sponsor
- Lead sponsor
- Transonic Systems Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- National Heart, Lung, and Blood Institute (NHLBI)
- First posted
- Jun 4, 2012
Design
- Study type
- Observational
- Who can join
- All sexes, up to 1 month
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Presently there is no apparatus, clinically available, for routine determination of cardiac output (CO) in children. The goal of this research is to develop new technology that will help determine CO in neonates.
Conditions
- Neonatal Intensive Care
Interventions
COstatus cardiac output measurement with isotonic salineDevice
Isotonic saline, which is the indicator, is injected to obtain COstatus cardiac output measurements. No other interventions are made for the purpose of the study.
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Crouse Hospital
Syracuse, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.